Professor Andrew Krentz chairs the first annual European Health Innovation Collaborative conference at Imperial College London
22 September 2016
Senior members of the Institute for Translational Medicine (Professor Andrew Krentz, Dr Claire Stocker; Dr Moh Tadayyon) participated in a state-of-the-art symposium focused on new drug therapies for type 2 diabetes. The update was part of the first annual European Health Innovation Collaborative conference at Imperial College London. Professor Krentz was the inaugural conference chairman. The University of Buckingham Symposium – Diabetes: Too Many Drugs, Too Many Guidelines? – chronicled the contributions of the Clore Life Sciences laboratory to diabetes drug development and considered innovative therapeutic developments. It was concluded that recent clinical trials have opened up a new era for diabetes pharmacotherapy that will require a major re-evaluation of current treatment strategies. Other topics covered during the wide-ranging conference included the latest generation of gene editing technology, robotics-assisted cancer surgery, and the evolving digital medicine space. Details at www.euhic.com. It is hoped that the next EUHIC conference will be held in Berlin in September 2017.